Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department: The De-Label Program Expansion

NCT06823154 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT06823154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06823154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department: The De-Label Program Expansion
Lead sponsor
The Hospital for Sick Children
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 27, 2023
Completion date
December 31, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy amoxicillin, beta-lactam allergy labels